Literature DB >> 2827884

Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features.

K Komaki1, G Sakamoto, H Sugano, T Morimoto, Y Monden.   

Abstract

In 175 women with mucinous carcinoma (MC) of the breast, the morphologic features, the clinicopathological features (age, tumor size, and nodal status) and prognoses were investigated. They were divided into two types, those with "unmixed type" (n = 140) showing no component of invasive ductal carcinoma (IDC) and "mixed type" (n = 35) including an IDC component. The unmixed type showed less frequent (P less than 0.01) nodal involvement and a higher degree (P less than 0.005) of extracellular mucus production than the mixed type. The presence of nodal metastases showed no correlation with the degree of mucus production. The 10-year survival rate of the unmixed type (90.4%) was better (P less than 0.001) than in the mixed type (66.0%). In the unmixed type, a higher level of mucus production showed trends toward a better prognosis, younger age and smaller tumor size (P less than 0.01). In the mixed type, the degree of mucus production showed no significant correlation with either the age, tumor size, or prognosis. It is more important for the prognosis of patients with MC to have no IDC component than to show abundant mucus within the tumor.

Entities:  

Mesh:

Year:  1988        PMID: 2827884     DOI: 10.1002/1097-0142(19880301)61:5<989::aid-cncr2820610522>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  Cystic Hypersecretory Duct Carcinoma of the Breast:A Case Reprot Describing the Cytologic Features.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  Not all "mucinous carcinomas" are equal: time to redefine and reinvestigate the biologic significance of mucin types and patterns in the GI tract.

Authors:  N Volkan Adsay; David S Klimstra
Journal:  Virchows Arch       Date:  2005-06-08       Impact factor: 4.064

3.  Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast.

Authors:  D Hawes; R Robinson; R Wira
Journal:  Gastrointest Radiol       Date:  1991

4.  Expression of vascular endothelial growth factor and caspase-3 in mucinous breast carcinoma and infiltrating ductal carcinoma-not otherwise specified, and the correlation with disease-free survival.

Authors:  Qiuli Wang; Lisha Sun; Jici Yan; Shuo Wang; Juncheng Zhang; Xinyu Zheng
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

5.  Management of Rare Histological Types of Breast Tumours.

Authors:  Toralf Reimer
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

6.  Identification of a lower grade muconodular subtype of gastric mucinous cancer.

Authors:  Enrico Solcia; Ombretta Luinetti; Francesca Tava; Catherine Klersy; Federica Grillo; Nicola Pandolfo; Roberto Fiocca
Journal:  Virchows Arch       Date:  2004-10-28       Impact factor: 4.064

7.  Oestrogen receptors in mucinous carcinoma of the breast: an immunohistological study using paraffin wax sections.

Authors:  S Shousha; A T Coady; T Stamp; K R James; J Alaghband-Zadeh
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

8.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

9.  Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.

Authors:  Seho Park; Jaseung Koo; Joo-Hee Kim; Woo Ick Yang; Byeong-Woo Park; Kyong Sik Lee
Journal:  J Korean Med Sci       Date:  2010-02-19       Impact factor: 2.153

10.  Clinicopathological characteristics and prognosis of mucinous breast carcinoma.

Authors:  Ming Zhang; Xiao-Dan Teng; Xin-Xin Guo; Ji-Shuang Zhao; Zhi-Gao Li
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-05       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.